Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-16071 · Session 5

 which research projects relating to Parkinson's disease it has funded since 1999, and what the funding commitment was to each project.

Answered Asked by Jackie Baillie Lab Lodged 19 Apr 2018

The question

To ask the Scottish Government which research projects relating to Parkinson's disease it has funded since 1999, and what the funding commitment was to each project.

The answer

Answered by Shona Robison on 26 Apr 2018 · 7 days after it was lodged, on time

Researchers can apply to the Chief Scientist Office for funding. The CSO's Translational Clinical Studies Committee and the Health Improvement, Protection and Services Research Committees each meet twice per year to consider funding applications. Details of the application process are published on the CSO website.
http://www.cso.scot.nhs.uk/funding-2/

Research proposals in Parkinson’s Disease (including research into the underlying mechanisms and causes, diagnosis, prevention, disease-modifying treatments, care pathways etc.) are welcomed. In common with all other applications, any such proposals would be subject to the Chief Scientist Office’s standard independent expert review process.

Since 1999 the following projects in Parkinson's Disease have been funded by CSO

Identification of prognostic factors and development of prognostic models in Parkinson's disease using long-term data from a large incidence-based cohort
Funding commitment £194,985

Improving predictions of prognosis in Parkinson's: moving from intensive small-scale studies to large and reliable routinely-collected datasets
Funding commitment £20,000

The Chief Scientist Office has an active programme of co-funding research with 3rd sector organisations. Officials from CSO are currently in discussion with Parkinson's UK around potential areas of collaboration.

The Scottish Government provides annual funding of over £490,000 for the Scottish Dementia and Neuroprogressive Disease Research Network. The network supports a wide range of research studies in Neuroprogressive disease, including Parkinson’s.

In the Official Report

No contribution in the Official Report cites S5W-16071 by reference.